Dr. Sanjay Agarwala is a distinguished orthopaedic surgeon and clinician-scientist whose career exemplifies the seamless integration of pioneering research with high-volume specialist practice.

With an h-index of 22 and nearly 100 peer-reviewed publications, he is internationally recognised for transforming the management of avascular necrosis (AVN) by pioneering the first widely adopted disease-modifying, non-surgical bisphosphonate  treatment protocol, fundamentally altering the natural history of this disabling condition. His research is characterised by rigorous prospective long-term follow-up, clinically meaningful outcomes, and sustained international citation impact.

He has also advanced function-centric hip and knee arthroplasty, restoring culturally relevant activities such as squatting and sitting cross-legged, exemplifying translational innovation that has reshaped contemporary orthopaedic practice.